Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-hCG for Breast Cancer Prevention in BRCA Carriers
NCT03495609Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human chorionic gonadotrophin in breast cancer, sponsored by Ghent University Hospital. Started Feb 2016; status: completed.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03495609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03495609.